Management of severe corporeal fibrosis with implantation of prosthesis via a transverse scrotal approach.
OBJECTIVE
We reviewed our experience in the management of severe corporeal fibrosis with placement of the AMS 700 CXM* prosthesis to determine the efficacy of this approach.


METHODS
The records of 26 men with severe corporeal fibrosis who underwent placement of the AMS 700 CXM prosthesis via a transverse scrotal approach between August 1991 and July 1996 were reviewed.


RESULTS
In all cases the AMS 700 CXM prosthesis was successfully implanted with primary closure of the tunica albuginea, although 2 patients required extended corporotomies. Followup data were available on all 26 men. At a mean followup of 22.5 months (range 3 to 63) 24 of the 26 men had a functional device (92%). One patient required explantation for infection and 1 underwent explantation for cylinder cross-over.


CONCLUSIONS
Implantation of the AMS 700 CXM prosthesis in patients with severe corporeal fibrosis produced good results at approximately 2 years of followup.
Carbone
D J
DJ
Department of Urology, Cleveland Clinic Foundation, Ohio, USA.
Daitch
J A
JA
Angermeier
K W
KW
Lakin
M M
MM
Montague
D K
DK
D000328:Adult; D000368:Aged; D005355:Fibrosis; D006801:Humans; D008297:Male; D008875:Middle Aged; D019935:Penile Implantation; D015917:Penile Prosthesis; D010413:Penis / Q000473:pathology*